Critical role of Fas/Fas ligand interaction in CD28-independent pathway of allogeneic murine hepatocyte rejection

Hepatology

Volumn 26, Issue 4, 1997, Pages 944-948

  Kawahara, Toshiyasu ^a,b,c   Kasai, Shinichi ^a   Yagita, Hideo ^b   Sawa, Masayuki ^a   Kato, Kazuya ^a   Azuma, Miyuki ^b   Nakajima, Atsuo ^b   Okumura, Ko ^b   Futagawa, Shunji ^b   Mito, Michio ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; FAS ANTIGEN; LACTATE DEHYDROGENASE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PERFORIN; T LYMPHOCYTE RECEPTOR;

ALLOGRAFT; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MEDIATED CYTOTOXICITY; GRAFT SURVIVAL; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSPLANTATION;

EID: 12644263393     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260421     Document Type: Article

References (29)

1. Bumgardner GL, Fasola C, Sutherland DE. Prospects for hepatocyte transplantation. HEPATOLOGY 1988;8:1158-1161.
2. Mito M, Ebata H, Kusano M, Onishi T, Saito T, Sakamoto S. Morphology and function of isolated hepatocytes transplanted into rat spleen. Transplantation 1979;28:499-505.
3. Ebata H, Oikawa I, Mito M. Rejection of allogeneic hepatocytes and fetal hepatic tissue transplanted into the rat spleen. Transplantation 1985;39:221-223.
4. Bretscher P. The two-signal model of lymphocyte activation twenty-one years later. Immunol Today 1992;13:74-76.
5. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-480.
6. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990;248:1349-1356.
7. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LEA-1. Science 1992;255:1125-1127.
8. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 1992;257:789-792.
9. Lenschow DJ, Zeng Y, Hathcock KS, Zuckerman LA, Freeman G, Thistlethwaite JR, Gray GS, et al. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 1995;60:1171-1178.
10. Turka LA, Linsley PS, Lin H, Brady W, Leiden JM, Wei RQ, Gibson ML, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A 1992;89:11102-11105.
11. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994;15:321-331.
12. Azuma M, Cayabyab M, Phillips JH, Lanier LL. Requirements for CD28-dependent T cell-mediated cytotoxicity. J Immunol 1993;150:2091-2101.
13. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994;76:959-962.
14. Ogasawara J, Watanabe FR, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-809.
15. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
16. Yagita H, Nakata M, Kawasaki A, Shinkai Y, Okumura K. Role of perform in lymphocyte-mediated cytolysis. Adv Immunol 1992;51:215-242.
17. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, et al. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994;265:528-530.
18. + T cells. Immunol Rev 1995;146:223-239.
19. Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, et al. Fas and its ligand in a general mechanism of T-cell-mediated cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1994;91:4930-4934.
20. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-1456.
21. Klaunig JE, Goldblatt PJ, Hinton DE, Lipsky MM, Chacko J, Trump BF. Mouse liver cell culture. I. Hepatocyte isolation. In Vitro 1981;17: 913-925.
22. Nakajima A, Azuma M, Kodera S, Nuriya S, Terashi A, Abe M, Hirose S, et al. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur J Immunol 1995;25:3060-3069.
23. Seino K, Kayagaki N, Bashuda H, Okumura K, Yagita H. Contribution of Fas ligand to cardiac allograft rejection. Int Immunol 1996;8:1347-1354.
24. Decker T, Lohmann MM. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988;115:61-69.
25. Anel A, Buferne M, Boyer C, Schmitt VA, Golstein P. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol 1994;24:2469-2476.
26. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P. TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 1995;181:781-786.
27. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230.
28. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. HEPATOLOGY 1994;19:1354-1359.
29. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura K, Ogasawara J, Nagata S. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res 1994;215:332-337.